<DOC>
	<DOCNO>NCT01310790</DOCNO>
	<brief_summary>The impact lactate guide therapy septic shock extensively investigate , however goal direct therapy use year . The investigator aim test hypothesis lactate direct hemodynamic therapy associate improve outcome patient septic shock compare different goal direct strategy commonly recommend clinically . In multicenter , randomize trial , investigator assign patient septic shock three group : Patients treat hemodynamic therapy direct either conventional parameter treatment ( control group ) , central venous oxygen saturation ( ScvO2 ) , blood lactate respectively group . The primary outcome rate death 28 day randomization in-hospital mortality ; secondary end point include hemodynamic state , time goal-achievement .</brief_summary>
	<brief_title>Strategy Early Improvement Tissue Oxygenation Decrease Mortality Severe Sepsis Septic Shock</brief_title>
	<detailed_description>This prospective , randomize , control multi-center study perform 6 close intensive care unit ( ICU ) academic tertiary hospital . Adult patient septic shock admit hospital 2005 2008 assign study eligibility . Eligible patient centrally randomize use sealed envelope one three group include lactate , ScvO2 , control group . The criterion septic shock include two four criterion systemic inflammatory response syndrome systolic blood pressure low 90 mmHg decrease systolic blood pressure 40 mmHg fluid challenge clinical sign tissue hypoperfusion , include oliguria , blood lactate concentration 4 mmol/L consciousness alteration . The patient exclude meet one follow : age le 18 year , pregnancy , acute cerebral vascular event ( Glasgow coma score &lt; 5 ) , acute myocardial infarction acute coronary syndrome , massive pulmonary embolism , status asthmaticus , primary diagnose cardiac dysrhythmias , contraindication central venous catheterization , active gastrointestinal hemorrhage , massive intraabdominal infective focus without drainage , severe bronchopleural fistula , seizure , chemotherapy immunosuppressive therapy , end stage disease . The protocol approve Institutional Ethics Committee . The informed consent obtain patient legally authorize next kin . The patient legal surrogate decision maker inform right refuse study procedure time protocol perform . The case report form ( CRF ) send site principal investigator protocol , randomly seal serial envelope . After patient ' enrollment , CRFs fill attend physician site accord protocol group . End point 28-day mortality in-hospital mortality 90 day . The demographic data , acute physiological chronic evaluation score ( APACHE ) II data patient ' basic condition record enrollment day . The protocol relate data collect baseline hour 6 hour 12 , 24 , 36 , 48 , 60 , 72 hour . The ICU hospital length stay also note patient follow day 28 discharge hospital mortality . The protocol implementation data collection stop patient family wish withdraw program refuse treatment patient 's death .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>severe sepsis septic shock patient &lt; 18 year old ; pregnant woman ; AMI ; cerebral hemorrhage ; contraindication SG catheter Brainstem death</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>septic shock</keyword>
	<keyword>lactic acid clearance</keyword>
	<keyword>ScVO2</keyword>
</DOC>